APA (7e ed.) Bronvermelding

Supphachoke Khemla, Atibordee Meesing, Wantin Sribenjalux, & Ploenchan Chetchotisakd. (2023). Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. AboutScience Srl.

Chicago (17e ed.) Bronvermelding

Supphachoke Khemla, Atibordee Meesing, Wantin Sribenjalux, en Ploenchan Chetchotisakd. Lipid Profiles of People with Human Immunodeficiency Virus with Dyslipidemia After Switching from Efavirenz to Dolutegravir. AboutScience Srl, 2023.

MLA (9e ed.) Bronvermelding

Supphachoke Khemla, et al. Lipid Profiles of People with Human Immunodeficiency Virus with Dyslipidemia After Switching from Efavirenz to Dolutegravir. AboutScience Srl, 2023.